AR049028A1 - Sal solida farmaceuticamente adecuada y que no sublima del enantiomero s de mirtazapina y metodo de fabricacion - Google Patents

Sal solida farmaceuticamente adecuada y que no sublima del enantiomero s de mirtazapina y metodo de fabricacion

Info

Publication number
AR049028A1
AR049028A1 ARP050101549A ARP050101549A AR049028A1 AR 049028 A1 AR049028 A1 AR 049028A1 AR P050101549 A ARP050101549 A AR P050101549A AR P050101549 A ARP050101549 A AR P050101549A AR 049028 A1 AR049028 A1 AR 049028A1
Authority
AR
Argentina
Prior art keywords
mirtazapine
enantiomer
manufacturing
sublimate
solid salt
Prior art date
Application number
ARP050101549A
Other languages
English (en)
Spanish (es)
Inventor
Sytske Hyke Moolenaar
Der Voort Maarschalk Kees Van
Gerardus Johannes Kemperman
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of AR049028A1 publication Critical patent/AR049028A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP050101549A 2004-04-21 2005-04-20 Sal solida farmaceuticamente adecuada y que no sublima del enantiomero s de mirtazapina y metodo de fabricacion AR049028A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04101664 2004-04-21

Publications (1)

Publication Number Publication Date
AR049028A1 true AR049028A1 (es) 2006-06-21

Family

ID=34928990

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101549A AR049028A1 (es) 2004-04-21 2005-04-20 Sal solida farmaceuticamente adecuada y que no sublima del enantiomero s de mirtazapina y metodo de fabricacion

Country Status (31)

Country Link
US (1) US20070111993A1 (https=)
EP (1) EP1729777B1 (https=)
JP (2) JP5260959B2 (https=)
CN (2) CN1942191B (https=)
AR (1) AR049028A1 (https=)
AT (1) ATE424210T1 (https=)
AU (1) AU2005235383B2 (https=)
BR (1) BRPI0509953A (https=)
CA (1) CA2561281C (https=)
CY (1) CY1109018T1 (https=)
DE (1) DE602005013066D1 (https=)
DK (1) DK1729777T3 (https=)
EC (1) ECSP066938A (https=)
ES (1) ES2321961T3 (https=)
HR (1) HRP20090190T1 (https=)
IL (1) IL178201A (https=)
LV (1) LV13556B (https=)
MX (1) MXPA06011830A (https=)
MY (1) MY144899A (https=)
NO (1) NO20065077L (https=)
NZ (1) NZ550052A (https=)
PE (1) PE20060400A1 (https=)
PL (1) PL1729777T3 (https=)
PT (1) PT1729777E (https=)
RS (1) RS50764B (https=)
RU (1) RU2375362C2 (https=)
SI (1) SI1729777T1 (https=)
TW (1) TW200538100A (https=)
UA (1) UA89773C2 (https=)
WO (1) WO2005102352A1 (https=)
ZA (1) ZA200608305B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
EP1792618A1 (en) * 2005-11-30 2007-06-06 Rainer Freynhagen R-mirtazapine for the treatment of pain
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
CN104095824B (zh) * 2013-04-09 2016-08-31 上海信谊万象药业股份有限公司 一种米氮平缓释片及其制备方法
PL3261645T3 (pl) 2015-02-27 2021-12-06 Dechra Limited Pobudzanie apetytu, zarządzanie utratą masy ciała, i leczenie anoreksji u psów i kotów
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4193828A (en) * 1976-07-27 1980-03-18 Fiber Materials, Inc. Method of forming carbon composites
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
WO1999051237A1 (en) * 1998-04-02 1999-10-14 Akzo Nobel N.V. Oral liquid antidepressant solution
WO2001000196A2 (en) * 1999-06-25 2001-01-04 University Of South Florida Mirtazapine for weight gain in wasting diseases
US6281207B1 (en) * 1999-09-15 2001-08-28 Reed Richter Treatment of movement disorders by administration of mirtazapine
WO2001042239A1 (en) * 1999-12-13 2001-06-14 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
SK14162002A3 (sk) * 2000-04-05 2003-03-04 Akzo Nobel N.V. Kombinácia obsahujúca paracetamol alebo nesteroidné protizápalové liečivo, použitie mirtazapínu, paracetamolu a pacientský balíček

Also Published As

Publication number Publication date
EP1729777B1 (en) 2009-03-04
CN1942191A (zh) 2007-04-04
EP1729777A1 (en) 2006-12-13
PL1729777T3 (pl) 2009-07-31
TW200538100A (en) 2005-12-01
CA2561281C (en) 2013-04-02
ZA200608305B (en) 2008-08-27
BRPI0509953A (pt) 2007-09-25
CN1942191B (zh) 2011-02-02
US20070111993A1 (en) 2007-05-17
AU2005235383A1 (en) 2005-11-03
NO20065077L (no) 2006-11-14
CN101824035A (zh) 2010-09-08
SI1729777T1 (sl) 2009-08-31
CA2561281A1 (en) 2005-11-03
CY1109018T1 (el) 2014-07-02
IL178201A (en) 2010-06-30
PE20060400A1 (es) 2006-05-27
WO2005102352A1 (en) 2005-11-03
UA89773C2 (ru) 2010-03-10
IL178201A0 (en) 2006-12-31
LV13556B (en) 2007-07-20
RS50764B (sr) 2010-08-31
MY144899A (en) 2011-11-30
ECSP066938A (es) 2006-12-20
JP5260959B2 (ja) 2013-08-14
JP2007533705A (ja) 2007-11-22
HRP20090190T1 (en) 2009-05-31
DK1729777T3 (da) 2009-06-08
NZ550052A (en) 2010-02-26
ATE424210T1 (de) 2009-03-15
MXPA06011830A (es) 2007-03-23
ES2321961T3 (es) 2009-06-15
AU2005235383B2 (en) 2010-05-27
RU2006140988A (ru) 2008-05-27
JP2013136626A (ja) 2013-07-11
DE602005013066D1 (de) 2009-04-16
RU2375362C2 (ru) 2009-12-10
PT1729777E (pt) 2009-04-27

Similar Documents

Publication Publication Date Title
CL2009000903A1 (es) Composiciones farmacéuticas que comprenden un núcleo que contiene una droga débilmente básica seleccionada de derivados de butirofenona, una capa de amortiguador de ph alcalino y un recubrimiento de liberación controlada, método para preparar dichas composiciones y formas de dosificación farmacéutica que las incluyen.
AR054114A1 (es) Composiciones farmaceuticas que comprenden imatinib y un retardador de la liberacion
UY29199A1 (es) Derivados tiazol, composiciones que los contienen, procedimientos de preparación y aplicaciones
NO20081569L (no) Administrasjon av dipeptidylpeptildaseinhibitorer
CL2007001918A1 (es) Compuestos derivados heteroarilos sustituidos; metodo para la preparacion de los compuestos; composicion farmaceutica; y uso para el tratamiento del dolor, depresion, enfermedad de alzheimer e hipertension entre otras.
CR11678A (es) Combinaciones de un conjugado anticuerpo-farmaco anti-her2 y agentes quimioterapeuticos y los metodos de uso
ECSP056020A (es) Inhibidores del factor inhibidor de la migración de los macrofagos y metodos para su identificacion
UY29781A1 (es) Compuestos diazaspiro sustituidos, sales farmacéuticamente aceptables, composiciones farmacéuticas que contienen los compuestos o sales, métodos de preparación y usos
CR6436A (es) Inhibidores de la receptacion de monoaminas para el tratamiento de trastornos del snc
AR063538A1 (es) Tratamiento de la enfermedad de parkinson
CL2009001346A1 (es) Compuestos derivados heterociclicos, inhibidores de la adn girasa; proceso de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion bacteriana.
PA8597301A1 (es) Derivados de imidazol-4-il-etinil-piridina
AR051653A1 (es) Formulaciones
HN2006007884A (es) Derivados de oxiindol
AR082493A1 (es) Formulaciones a base de nalbufina, y sus utilizaciones
ES2523518T3 (es) Nuevas combinaciones farmacológicas para el tratamiento de enfermedades de las vías respiratorias
CY1125224T1 (el) Κρυσταλλικες μορφες 1-(3-τριτ-βουτυλο-1-ρ- τολυλο-1η-πυραζολ-5-υλο)-3-(5-φθορο-2-(1-(2- υδροξυαιθυλ)-ινδαζολ-5-υλοξυ)βενζυλ)ουριας υδροχλωρικη
EA201000039A1 (ru) Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль
ECSP088250A (es) Derivados de pirazol como agentes terapéuticos
MX2019003317A (es) Metodo para tratar cancer usando una combinacion de agentes que dañan adn e inhibidores de proteina cinasa dependiente de adn (adn-pk).
CY1109018T1 (el) Φαρμακευτικη συνθεση που περιεχει ενα αλας μιρταζαπινης
ES2581331T3 (es) Inhibidor de la progresión de una enfermedad atribuida a una acumulación anormal de grasa hepática
ES2582660T3 (es) Sidnoniminas - inhibidores específicos de la recaptación de la dopamina y su uso en el tratamiento de los trastornos relacionados con la dopamina
AR077692A1 (es) Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
AR058047A1 (es) Administracion de inhibidores de dipeptidil peptidasa

Legal Events

Date Code Title Description
FB Suspension of granting procedure